| Symbol | SLN |
|---|---|
| Name | SILENCE THERAPEUTICS PLC |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 12 HAMMERSMITH GROVE, LONDON, None W6 7AP |
| Telephone | 44-0-20-3457 6900 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001479615 |
| Description | None |
Silence Therapeutics - Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’Option to Purchase Additional ADSs
Read moreSilence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
Read moreNew Form SCHEDULE 13D/A - Silence Therapeutics plc <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001104659-26-096202 <b>Size:</b> 19 KB
Read moreGriffiths Richard Ian 🟢 acquired 16.5M shares (11 derivative) of Silence Therapeutics plc (SLN) at $16.35 ($263.3M) Transaction Date: Aug 10, 2026 | Filing ID: 095574
Read moreNew Form SCHEDULE 13G/A - Silence Therapeutics plc <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0002005369-26-000047 <b>Size:</b> 21 KB
Read moreNew Form 424B5 - Silence Therapeutics plc <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001193125-26-347191 <b>Size:</b> 866 KB
Read moreSilence Therapeutics - Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
Read moreSilence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
Read moreNew Form S-3MEF - Silence Therapeutics plc <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001193125-26-345465 <b>Size:</b> 268 KB
Read more